The opioid epidemic continues to consume the United States. In 2016, more than 42,000 people died of opioid overdoses and recent estimates put the cost of the opioid epidemic in excess of $500 billion annually.
States are addressing this widespread tragedy at its root cause: opioid prescribing. However, the whos, whats, whys and hows of these key strategies vary widely across the country.
The Fighting the Opioid Epidemic at the State- and Rx-Level report was designed to provide health care executives, law enforcement and government leaders a unified view of state and federal efforts to combat the opioid crisis at the prescribing level. Updated through July 2018, it focuses on the range of state responses to the opioid epidemic.
The Fighting the Opioid Epidemic at the State- and Rx-Level report is a helpful companion piece to the ePrescribing State Law On-Demand research brief. When purchased together, the Opioid report is discounted to $495.
The Fighting the Opioid Epidemic at the State- and Rx-Level report can also be purchased at the discounted $495 price for customers currently subscribed to the ePrescribing State Law Review. Contact us to purchase.
The 39-page report includes details of state responses to opioid prescribing organized around three main trends: 1) prescribing, 2) curbing fraud and abuse, and 3) preventing and treating addiction.
The analyses are supplemented with 12 figures, including state maps indicating required consultation of Prescription Drug Monitoring Programs (PDMPs) by prescribers and dispensers. A third map focuses on states that have mandated electronic prescribing of controlled substances (EPCS) or proposed doing so.
Specific details are summarized in two Appendices. Appendix A provides a state-by-state overview of controlled substance rules and limits. Appendix B highlights controlled substance mid-level prescribing authorities.
Partial View of Appendix A
This July 2018 report has new and detailed data on state responses to opioid prescribing. Among the major findings:
Want to learn more? Click here for a report preview. POCP’s Regulatory Resource Center also can do a deep dive on this and other state prescribing-related issues. For more information, contact email@example.com.